← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2017Last known activity
Mar 25, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT06361485Lead sponsorPhase 1Mar 25, 2024
- NCT03390920Lead sponsorPhase 2/Phase 3Jun 1, 2017
Details
- Last known activity
- Mar 25, 2024